TNFRSF10B and cancer: Cisplatin enhances the sensitivity of COLO205 and MDA-MB-231 cancer cells to apoptosis mediated by TR2-3, a novel agonistic single-chain antibody targeting DR5, by increasing DR5 expression (Lei et al., 2018)